Skip to menu Skip to content Skip to footer
Professor Sandro Porceddu
Professor

Sandro Porceddu

Email: 

Overview

Background

Profile Summary

Dr Sandro Porceddu is an internationally recognised radiation oncologist and a leading authority in head and neck and skin cancer. With over 20 years experience in medicine his areas of clinical expertise include head and neck cancer, skin cancer, sarcoma and lymphoma. He is currently a senior radiation oncologist and Director of radiation oncology research at the Princess Alexandra Hospital, Brisbane, Professor of Medicine, University of Queensland and Associate Editor for the International Head and Neck journal, Oral Oncology.

Dr Porceddu is a nationally and internationally recognised cancer advocate through his involvement in high-level committees, engagement with key policymakers, community education and media roles.

Career Summary

Professor Porceddu completed his medical degree at Monash University before undertaking his residency at Monash Medical Centre, Melbourne. He commenced his specialist training in radiation oncology at the Peter MacCallum Cancer Centre in 1996 and was made Fellow of the Royal Australian and New Zealand College of Radiologists, Faculty of Radiation Oncology in 2000. After working as a consultant radiation oncologist at PeterMac for several years he moved to the Princess Alexandra Hospital in 2004.

Professional Committees and Organisations

Professor Porceddu has been the President of the Clinical Oncology Society of Australia (COSA), the peak organisation for cancer-related health professionals, and the Trans Tasman Radiation Oncology Group (TROG), one of the largest cancer collaborative trials group in Australia/New Zealand. He has served on numerous national and international professional and academic committees including the board of the Cancer Council of Australia, the National Cancer Expert Reference Group for the Commonwealth and the International Union for the Control of Cancer (UICC) TNM Expert Advisory Panel.

Currently, he is the Chair of the Cancer Council Queensland Co-operative Oncology Group, a committee that provides over $1.2M per annum to support clinical research throughout Queensland and is on the board of the of the Head and Neck Cancer InterGroup (HNCIG), a group of leading world cancer experts dedicated to promoting the global harmonisation of head and neck cancer research and treatment.

Academic Highlights

Professor Porceddu runs an active clinical research program with over 150 peer-review articles, book chapters, published abstracts, invited reviews and commentaries. He has received invitations to speak at major international conferences such as the American Society of Clinical Oncology (ASCO) meeting and publish in prestigious journals such as the Lancet Oncology and Journal of Clinical Oncology.

Awards

Trans Tasman Radiation Oncology Group Outstanding Contribution

American Head and Neck Society Chris O’Brien Travelling Scholar

Pre-eminent status by Queensland Health

Rouse Fellowship, Royal Australian and New Zealand College of Radiologists

Teaching

Dr Porceddu has had a life-long commitment to teaching and is a supervisor and mentor to Doctor of Philosophy and Master of Philosophy candidates, Clinical Research Fellows, MBBS Honours students, resident, registrars and other allied health professionals.

Availability

Professor Sandro Porceddu is:
Available for supervision

Qualifications

  • Bachelor of Science, Monash University
  • Bachelor of Medicine and Surgery and Medical Science, Monash University
  • Doctoral Diploma of Medicine, The University of Queensland

Research impacts

Dr Porceddu’s has been investigating methods to reduce the morbidity of treatment, improve cure rates and quality of life for cancer patients. He runs an active head and neck/skin cancer research program and is the principal investigator of numerous trials including an NHMRC-supported Randomised Phase III trial on head and neck skin cancer (POST TROG 05.01). In line with his research goals he has been examining the integration of radiation therapy and new technologies in the management of head and neck cancer and has received his Doctorate of Medicine (MD) on this topic with UQ. His current research on Positron Emission Tomography in the management of the neck following chemo-radiotherapy has been internationally recognised and incorporated into the USA National Comprehensive Cancer Network (NCCN) guidelines. He has been the recipient of over $3.91M in competitive funding, including one recently closed and two open NHMRC grants.

Works

Search Professor Sandro Porceddu’s works on UQ eSpace

176 works between 1999 and 2025

161 - 176 of 176 works

2006

Journal Article

Keystone island flap: An alternative reconstructive option to free flaps in irradiated tissue

Behan, F, Sizeland, A, Porcedu, S, Somia, N and Wilson, J (2006). Keystone island flap: An alternative reconstructive option to free flaps in irradiated tissue. ANZ Journal of Surgery, 76 (5), 407-413. doi: 10.1111/j.1445-2197.2006.03708.x

Keystone island flap: An alternative reconstructive option to free flaps in irradiated tissue

2005

Journal Article

Parotid-sparing radiotherapy: does it really reduce xerostomia?

Ng, M. K., Porceddu, S. V., Milnert, A. D., Corry, J., Hornby, C., Hope, G., Rischin, D. and Peters, L. J. (2005). Parotid-sparing radiotherapy: does it really reduce xerostomia?. Clinical Oncology, 17 (8), 610-617. doi: 10.1016/j.clon.2005.06.012

Parotid-sparing radiotherapy: does it really reduce xerostomia?

2005

Journal Article

The 'QUAD SHOT' - a phase II study of palliative radiotherapy for incurable head and neck cancer

Corry, June, Peters, Lester J., D'Costa, Ieta, Milner, Alvin D., Fawns, Helen, Rischin, Danny and Porceddu, Sandro (2005). The 'QUAD SHOT' - a phase II study of palliative radiotherapy for incurable head and neck cancer. Radiotherapy and Oncology, 77 (2), 137-142. doi: 10.1016/j.radonc.2005.10.008

The 'QUAD SHOT' - a phase II study of palliative radiotherapy for incurable head and neck cancer

2005

Journal Article

Results of treatment intensification for progressive locoregional disease in head-and-neck cancer patients undergoing postoperative radiotherapy

Corry, June, Rischin, Danny, Mukesh, Bickol N., Porceddu, Sandro and Peters, Lester J. (2005). Results of treatment intensification for progressive locoregional disease in head-and-neck cancer patients undergoing postoperative radiotherapy. International Journal of Radiation Oncology Biology Physics, 61 (5), 1416-1422. doi: 10.1016/j.ijrobp.2004.08.017

Results of treatment intensification for progressive locoregional disease in head-and-neck cancer patients undergoing postoperative radiotherapy

2005

Journal Article

Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo)radiotherapy in head and neck cancer

Porceddu, Sandro V., Jarmolowski, Elizabeth, Hicks, Rodney J., Ware, Rob, Weih, LeAnn, Rischin, Danny, Corry, June and Peters, Lester J. (2005). Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo)radiotherapy in head and neck cancer. Head and Neck, 27 (3), 175-181. doi: 10.1002/hed.20130

Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo)radiotherapy in head and neck cancer

2005

Conference Publication

Aggressive cutaneous squamous cell carcinoma (SCC) in chronic lymphocytic leukaemia (CLL)

Lane, S. W., Mollee, P. N., Bird, R., Porceddu, S. and Gill, D. (2005). Aggressive cutaneous squamous cell carcinoma (SCC) in chronic lymphocytic leukaemia (CLL). 47th Annual Meeting of the American Society of Hematology, Atlanta, GA, United States, 10-13 December 2005. Washington, DC, United States: American Society of Hematology.

Aggressive cutaneous squamous cell carcinoma (SCC) in chronic lymphocytic leukaemia (CLL)

2005

Conference Publication

The "quad shot" - palliative radiotherapy in locally advanced head and neck squamous cell carcinoma

Corry, J., D'costa, I., Milner, A., Fawns, H., Porceddu, S., Rischin, D. and Peters, L. (2005). The "quad shot" - palliative radiotherapy in locally advanced head and neck squamous cell carcinoma. 9th Nottingham International Breast Cancer Conference, Nottingham, United Kingdom, 13-16 September 2005. Oxford, United Kingdom: Elsevier.

The "quad shot" - palliative radiotherapy in locally advanced head and neck squamous cell carcinoma

2004

Journal Article

Usefulness of fluorine-18 fluorodeoxyglucose positron emission tomography in patients with a residual structural abnormality after definitive treatment for the head and neck

Ware, Robert E., Matthews, Jane P., Hicks, Rodney J., Porceddu, Sandro, Hogg, Annette, Rischin, Danny, Corry, June and Peters, Lester J. (2004). Usefulness of fluorine-18 fluorodeoxyglucose positron emission tomography in patients with a residual structural abnormality after definitive treatment for the head and neck. Head and Neck, 26 (12), 1008-1017. doi: 10.1002/hed.20097

Usefulness of fluorine-18 fluorodeoxyglucose positron emission tomography in patients with a residual structural abnormality after definitive treatment for the head and neck

2004

Journal Article

Outcomes in sinonasal mucosal melanoma

Martin, Jarad M., Porceddu, Sandro, Weih, LeAnn, Corry, June and Peters, Lester J. (2004). Outcomes in sinonasal mucosal melanoma. ANZ Journal of Surgery, 74 (10), 838-842. doi: 10.1111/j.1445-1433.2004.03185.x

Outcomes in sinonasal mucosal melanoma

2004

Conference Publication

The utility of PET for the detection of disease in residual neck nodes following (chemo)radiotherapy in head and neck cancer

Porceddu, SV, Corry, JF, Peters, LJ, Rischin, D and Hicks, RJ (2004). The utility of PET for the detection of disease in residual neck nodes following (chemo)radiotherapy in head and neck cancer. 23rd Annual Meeting of the European-Society-for-Therapeutic-Radiology-and-Oncology (ESTRO 23), Amsterdam Netherlands, Oct 24-28, 2004. CLARE: ELSEVIER IRELAND LTD.

The utility of PET for the detection of disease in residual neck nodes following (chemo)radiotherapy in head and neck cancer

2004

Conference Publication

Postoperative chemoradiotherapy for high-risk head-and-neck squamous cell carcinoma

Porceddu, SV, Campbell, B, Rischin, D, Corry, J, Weih, L, Guerrieri, M, Grossi, M and Peters, LJ (2004). Postoperative chemoradiotherapy for high-risk head-and-neck squamous cell carcinoma. 12th International Congress of Radiation Research, Brisbane Australia, 2003. NEW YORK: ELSEVIER SCIENCE INC. doi: 10.1016/j.ijrobp.2004.03.011

Postoperative chemoradiotherapy for high-risk head-and-neck squamous cell carcinoma

2004

Conference Publication

Superiority of tirapazamine-containing chemoradiation in head and neck cancers showing evidence of hypoxia on F-18-misonidazole (FMISO) pet scanning.

Hicks, R, Rischin, D, Fisher, R, Binns, D, Corry, J, Porceddu, S, Grossi, M, Okane, C and Peters, L (2004). Superiority of tirapazamine-containing chemoradiation in head and neck cancers showing evidence of hypoxia on F-18-misonidazole (FMISO) pet scanning.. 40th Annual Meeting of the American-Society-of-Clinical-Oncology, New Orleans La, Jun 05-08, 2004. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY.

Superiority of tirapazamine-containing chemoradiation in head and neck cancers showing evidence of hypoxia on F-18-misonidazole (FMISO) pet scanning.

2004

Journal Article

Promising results with chemoradiation in patients with sinonasal undifferentiated carcinoma

Rischin, D, Porceddu, S, Peters, L, Martin, J, Corry, J and Weih, L (2004). Promising results with chemoradiation in patients with sinonasal undifferentiated carcinoma. Head and Neck-Journal for the Sciences and Specialties of the Head and Neck, 26 (5), 435-441. doi: 10.1002/hed.10396

Promising results with chemoradiation in patients with sinonasal undifferentiated carcinoma

2004

Journal Article

Paranasal sinus tumors: Peter MacCallum Cancer Institute experience

Porceddu, S, Martin, J, Shanker, G, Weih, L, Russell, C, Rischin, D, Corry, J and Peters, L (2004). Paranasal sinus tumors: Peter MacCallum Cancer Institute experience. Head and Neck-Journal for the Sciences and Specialties of the Head and Neck, 26 (4), 322-330. doi: 10.1002/hed.10388

Paranasal sinus tumors: Peter MacCallum Cancer Institute experience

2001

Journal Article

Combined modality treatment using concurrent radiotherapy and pharmacologically-guided carboplatin for inoperable and incompletely resected non-small cell lung cancer

Grossi, M, Millward, M, Fisher, R, Porceddu, S, Mac Manus, M, Ryan, G, Wirth, A and Ball, D (2001). Combined modality treatment using concurrent radiotherapy and pharmacologically-guided carboplatin for inoperable and incompletely resected non-small cell lung cancer. Lung Cancer, 31 (1), 73-82. doi: 10.1016/S0169-5002(00)00164-1

Combined modality treatment using concurrent radiotherapy and pharmacologically-guided carboplatin for inoperable and incompletely resected non-small cell lung cancer

1999

Journal Article

Changing acute renal failure treatment from intermittent hemodialysis to continuous hemofiltration: impact on azotemic control

Bellomo, R, Farmer, M, Bhonagiri, S, Porceddu, S, Ariens, M, M'Pisi, D and Rongo, C (1999). Changing acute renal failure treatment from intermittent hemodialysis to continuous hemofiltration: impact on azotemic control. International Journal of Artificial Organs, 22 (3), 145-150.

Changing acute renal failure treatment from intermittent hemodialysis to continuous hemofiltration: impact on azotemic control

Funding

Past funding

  • 2019 - 2020
    Head and neck lymphoedema treatment: An examination and development of current standards of care
    PA Research Foundation
    Open grant
  • 2013 - 2016
    Can a computerised home therapy program provide an effective and cost-efficient model for delivering intensive swallowing therapy? An RTC of an innovative service model...
    Princess Alexandra Hospital
    Open grant
  • 2013 - 2015
    The role of epidermal growth factor receptor trafficking in tumor progression and patient therapy resistance
    Cancer Council Queensland
    Open grant
  • 2007 - 2011
    Post-operative concurrent chemo-radiotherapy versus post-operative radiotheray in high-risk cutaneous squamous cell carcinoma of the head and neck
    Queensland Health Smart Health Research Grant
    Open grant

Supervision

Availability

Professor Sandro Porceddu is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Media

Enquiries

For media enquiries about Professor Sandro Porceddu's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au